Efficacy and Safety Study of WVE-210201 (Suvodirsen) With Open-label Extension in Ambulatory Patients With Duchenne Muscular Dystrophy
Clinical trial NCT03907072 · TERMINATED
Trial details
- NCT number
- NCT03907072
- Sponsor
- Wave Life Sciences USA, Inc.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2019-12-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.